{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:24:54Z","timestamp":1789770294445,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ejps.2012.11.006","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T03:17:00Z","timestamp":1354072620000},"page":"332-338","source":"Crossref","is-referenced-by-count":30,"title":["Effect of volume ratio of ultrafiltrate to sample solution on the analysis of free drug and measurement of free carbamazepine in clinical drug monitoring"],"prefix":"10.1016","volume":"48","author":[{"given":"Wei-chong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.11.006_b0010","unstructured":"A patent of State Intellectual Property Office. Project No. 2009100744294."},{"key":"10.1016\/j.ejps.2012.11.006_b0005","first-page":"549","article-title":"Development of high-performance frontal analysis and the application to the study of drug plasma protein binding","volume":"8","author":"Akimasa","year":"1999","journal-title":"Trend. Anal. Chem."},{"key":"10.1016\/j.ejps.2012.11.006_b0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00007691-198802000-00002","article-title":"Problems in therapeautic drug monitoring: free drug level monitoring","volume":"10","author":"Barre","year":"1988","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2165\/00003088-197803020-00003","article-title":"Clinical pharmacokinetics of carbamazepine","volume":"3","author":"Bertilsson","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2012.11.006_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0928-0987(01)00220-2","article-title":"Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography\/ tandem mass spectrometry: important factors for method optimization","volume":"15","author":"Claudia","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.11.006_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2012.11.006_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2298\/VSP0905347D","article-title":"Determination ofcarbamazepinein serum and saliva samples by high performance liquid chromatography with ultraviolet detection","volume":"66","author":"Dordevi\u0107","year":"2009","journal-title":"Vojnosanit. Pregl."},{"key":"10.1016\/j.ejps.2012.11.006_b0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2008.11.010","article-title":"High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin","volume":"877","author":"Gianna","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejps.2012.11.006_b0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007691-198507030-00006","article-title":"Carbamazepineandcarbamazepine-epoxide serum protein binding in newborn infants","volume":"7","author":"Groce","year":"1985","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cpt1975174433","article-title":"Plasma protein binding of carbamazepine","volume":"17","author":"Hooper","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.11.006_b0055","first-page":"281","article-title":"Automated analysis of free and total concentration of three antiepileptic drugs in plasma with on-line dialysis and high-performance liquid chromatography","volume":"699","author":"Karianne","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.ejps.2012.11.006_b0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":"Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections","volume":"34","author":"Karine","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2012.11.006_b0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1365\/s10337-009-1257-y","article-title":"Hollow-fiber ultrafiltration then centrifugation for LC analysis of water-soluble sucrose in a water-soluble high-molecular-mass gel matrix","volume":"70","author":"Li","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.ejps.2012.11.006_b0065","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1016\/j.chroma.2010.08.059","article-title":"Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltrate device for the determination of cefaclor concentrations in human plasma","volume":"1217","author":"Li","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejps.2012.11.006_b0075","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jchromb.2011.05.012","article-title":"Developing a robust ultrafiltration-LC\u2013MS\/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma","volume":"879","author":"Li","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.ejps.2012.11.006_b0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.1981.tb01851.x","article-title":"Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients","volume":"12","author":"MacKichan","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.11.006_b0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007691-200306000-00025","article-title":"Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients","volume":"25","author":"Mandla","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jchromb.2005.11.035","article-title":"Liquid chromatography\u2013electrospray mass spectrometry determination of free and total concentrations of ropivacaine in human plasma","volume":"831","author":"Mathieu","year":"2006","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"issue":"27","key":"10.1016\/j.ejps.2012.11.006_b0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.ftd.0000173373.12569.c7","article-title":"Effect of ultrafiltrate volume on determination of free phenytoin concentration","volume":"2005","author":"McMillin","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chroma.2005.12.103","article-title":"Determination of unbound docetaxel and paclitaxel in plasma by ultrafiltration and liquid chromatography\u2013tandem mass spectrometry","volume":"1108","author":"Mortier","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejps.2012.11.006_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsps.2011.04.003","article-title":"Development and validation of an HPLC\u2013UV method for the quantification of carbamazepine in rabbit plasma","volume":"20","author":"Mowafy","year":"2012","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejps.2012.11.006_b0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clinbiochem.2010.09.025","article-title":"Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma","volume":"44","author":"Noem\u00ed","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejps.2012.11.006_b0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jpba.2011.01.034","article-title":"Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC\u2013MS\/MS","volume":"55","author":"Rakhila","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2012.11.006_b0120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00007691-198412000-00005","article-title":"Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects","volume":"6","author":"Riva","year":"1984","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/abio.2000.4863","article-title":"Cloud-point extraction for the determination of the free fraction of antiepileptic drugs in blood plasma and saliva","volume":"287","author":"Rukhadze","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2012.11.006_b0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jchromb.2004.12.005","article-title":"Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection","volume":"817","author":"Shen","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejps.2012.11.006_b0135","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/clinchem\/44.7.1481","article-title":"Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure","volume":"44","author":"Shipkova","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2012.11.006_b0140","first-page":"10","article-title":"Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents","volume":"50","author":"Steinborn","year":"2001","journal-title":"Rocz. Akad. Med. Bialymst."},{"key":"10.1016\/j.ejps.2012.11.006_b0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/clinchem.2003.024323","article-title":"Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid","volume":"50","author":"Streit","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2012.11.006_b0150","first-page":"1375","article-title":"Separation and determination of maltose in human normal immunoglobulin for intravenous by hollow fiber-high performance liquid chromatography","volume":"37","author":"Sun","year":"2009","journal-title":"Chinese J. Anal. Chem."},{"key":"10.1016\/j.ejps.2012.11.006_b0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007691-198609000-00011","article-title":"Clinical pharmacokinetics ofcarbamazepineand its epoxy and hydroxy metabolites in humans after an overdose","volume":"8","author":"Vree","year":"1986","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2012.11.006_b0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/03639040903154192","article-title":"Drug\u2013protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis","volume":"36","author":"Wang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2012.11.006_b0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clinbiochem.2009.12.005","article-title":"Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometry","volume":"43","author":"Yu","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejps.2012.11.006_b0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2006.05.042","article-title":"Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization","volume":"843","author":"Zhang","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2012.11.006_b0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug. Discov. Today"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712004642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712004642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:54:14Z","timestamp":1594950854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712004642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0928098712004642"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.11.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}